Design and synthesis of novel coumarin–benzimidazole hybrids as human galectin-1 inhibitors

Department of Biotechnology (DBT), Govt. of India, New Delhi, for the young investigators in cancer biology start up grants (6242-19/RGCB/PMD/DBT /MLKA/2015). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Comments (0)

No login
gif